Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris

Experimental Dermatology

Volumn 18, Issue 10, 2009, Pages 833-841

  Melnik, Bodo C ^a   Schmitz, Gerd ^b  

^a UNIVERSITY OF OSNABRÜCK   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Acne; Hyperglycaemic food; IGF 1; Insulin; Metformin; Milk; Smoking

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANDROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GROWTH HORMONE; INSULIN; ISOTRETINOIN; METFORMIN; PIOGLITAZONE; RECOMBINANT SOMATOMEDIN C; RETINOID; ROSIGLITAZONE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STEROID 5ALPHA REDUCTASE;

ACNE; ACNE VULGARIS; ACROMEGALY; AMENORRHEA; ANDROGEN SYNTHESIS; ANDROSTENEDIONE BLOOD LEVEL; CANCER RISK; DIETARY INTAKE; DISEASE ASSOCIATION; DOWN REGULATION; DRUG DOSE REDUCTION; DRUG MECHANISM; GLUCOSE INTAKE; HUMAN; INSULIN RESISTANCE; LARON SYNDROME; LIPOGENESIS; MILK; NONHUMAN; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEBACEOUS GLAND; SIDE EFFECT; SIGNAL TRANSDUCTION; SMOKING; TESTOSTERONE BLOOD LEVEL;

ACNE VULGARIS; ANIMALS; GLYCEMIC INDEX; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MILK;

EID: 70349849425     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00924.x     Document Type: Review

References (104)

1. Edmondson S R, Thumiger S P, Werther G A, Wraight C J. Epidermal homeostasis: the role of growth hormone and insulin-like growth factor systems. Endocr Rev 2003, 24:737-764.
2. Deplewski D, Rosenfield R L. Role of hormones in pilosebaceous unit development. Endocr Rev 2000, 21:363-392.
3. Deplewski D, Rosenfield R L. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999, 140:4089-4094.
4. Hansson H A, Nilsson A, Isgaard J. Immunohistochemical localization of insulin-like growth factor-I in the adult rat. Histochemistry 1988, 89:403-410.
5. Rudman S M, Philpott M P, Thomas G A, Kealey T. The role of IGF-I in human skin and its appendages: morphogen as well as mitogen?. J Invest Dermatol 1997, 109:770-777.
6. Fürstenberger G, Senn H-J. Insulin-like growth factors and cancer. Lancet 2002, 3:298-302.
7. Denley A, Cosgrove L J, Booker G W, Wallace J C, Forbes B E. Molecular interactions of the IGF system. Cytokine Growth Factor Rev 2005, 16:421-439.
8. Cara J F, Rosenfield R L, Furlanetto R W. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child 1987, 141:562-564.
9. Aizawa H, Niimura M. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 1995, 22:249-252.
10. Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 2005, 141:333-338.
11. Vora S, Ovhal A, Jerajani H, Nair N, Chakrabortty A. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol 2008, 159:979-995.
12. Downie M M, Sanders D A, Kealey T. Modelling the remission of individual acne lesions in vitro. Br J Dermatol 2002, 147:869-878.
13. Smith T M, Cong Z, Gilliland K L, Clawson G A, Thiboutot D M. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol 2006, 126:1226-1232.
14. Rosignoli C, Nicolas J C, Jomard A, Michel S. Involvement of the SREBP pathway in the mode of action of androgens in sebaceous glands in vivo. Exp Dermatol 2003, 12:480-489.
15. Eberle D, Hegarty B, Bossard P, Ferré P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004, 86:839-848.
16. Zouboulis C C. The human skin as a hormone target and an endocrine gland. Hormones 2004, 3:9-26.
17. Makrantonaki E, Vogel K, Fimmel S. Interplay of IGF-1 and 17β-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol 2008, 43:939-946.
18. Böhm M, Luger T A, Tobin D J, García-Borrón J C. Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol 2006, 126:1966-1975.
19. Zhang L, Anthonavage M, Huang Q. Proopiomelanocortin peptides and sebogenesis. Ann N Y Acad Sci 2003, 994:154-161.
20. Ganceviciene R, Graziene V, Böhm M, Zouboulis C C. Increased in situ expression of melanocortin-1 receptor in sebaceous glands of lesional skin of patients with acne vulgaris. Exp Dermatol 2007, 16:547-552.
21. Allen M, Grachtchouk M, Sheng H. Hedgehog signaling regulates sebaceous gland development. Am J Pathol 2004, 163:2173-2178.
22. Zhang L, Li W-H, Anthonavage M, Eisinger M. Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides 2006, 27:413-420.
23. Melnik B, Schmitz G. FGFR2 signaling and the pathogenesis of acne. J Dtsch Dermatol Ges 2008, 6:721-728.
24. Kaushansky A, Gordus A, Chang B, Rush J, MacBeath G. A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. Mol Biosyst 2008, 4:643-653.
25. Smith T M, Gilliland K, Clawson G A, Thiboutot D. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol 2008, 128:1286-1293.
26. Foretz M, Guichard C, Ferré P, Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 1999, 96:12737-12742.
27. Kallin A, Johannessen L E, Cani P D. SREBP-1 regulates the expression of heme oxygenase I and the phosphatidylinositol-3 kinase regulatory subunit p55gamma. J Lipid Res 2007, 48:1628-1636.
28. Reed B D, Charos A E, Szekely A M, Weissman S M, Snyder M. Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet 2008, 4:e1000133.
29. Solomon S S, Majumdar G, Martinez-Hernandez A, Raghow R. A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones. Life Sci 2008, 83:305-312.
30. Belgorosky A, Baquedano M S, Guerico G, Rivarola M A. Adrenarche: postnatal adrenal zonation and hormonal and metabolic regulation. Horm Res 2008, 70:257-267.
31. Mesiano S, Katz S L, Lee J Y, Jaffe R B. Insulin-like growth factors augment steroid production and expression of steroidogeneic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. J Clin Endocrinol Metabol 1997, 82:1390-1396.
32. Guerico G, Rivarola M A, Chaler E, Maceiras M, Belgorosky A. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab 2003, 88:1389-1393.
33. Giudice L C. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992, 13:641-669.
34. Cara J F. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res 1994, 42:49-54.
35. Wang G, Hardy M P. Development of Leydig cells in the insulin-like growth factor-I (IGF-I) knockout mouse: effects of IGF-I replacement and gonadotropic stimulation. Biol Reprod 2004, 70:632-639.
36. Lin T, Wang D L, Calkins J H, Guo H, Chi R, Housley P R. Regulation of insulin-like growth factor-I messenger ribonucleic acid expression in Leydig cells. Mol Cell Endocrinol 1990, 73:147-152.
37. Berensztein E B, Baquedano M S, Pepe C M. Role of IGFs and insulin in the human testis during postnatal activation: differentiation of steroidogenic cells. Pediatr Res 2008, 63:662-666.
38. Colón E, Svechnikov K V, Carlsson-Skwirut C, Bang P, Soder O. Stimulation of steroidogenesis in immature rat Leydig cells evoked by interleukin-1α is potentiated by growth hormone and insulin-like growth factors. Endocrinology 2005, 146:221-230.
39. Colón E, Zaman F, Axelson M. Insulin-like growth factor-I is an important antiapoptotic factor for rat Leydig cells during postnatal development. Endocrinology 2007, 148:128-139.
40. Horton R, Pasupuletti V, Antonipillai I. Androgen induction of 5α-reductase may be mediated via insulin-like growth factor-I. Endocrinology 1993, 133:447-451.
41. Fan W, Yanase T, Morinaga H. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor. J Biol Chem 2007, 282:7329-7338.
42. Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy. Gynecol Endocrinol 2004, 19:125-133.
43. Ibánez L, Ong K, Valls C, Marcos M V, Dunger D B, de Zegher F. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006, 91:2888-2891.
44. Guercio G, Rivarola M A, Chaler E, Maceiras M, Belgorosky A. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocr Metab 2003, 88:1389-1393.
45. Jensterle M, Janez A, Mlinar B, Marc J, Prezelj J, Pfeifer M. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. Eur J Endocrinol 2008, 158:793-801.
46. Pryor P R, Liu S C, Clark A E, Yang J, Holman G D, Tosh D. Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin. Biochem J 2000, 348:83-91.
47. Yang J, Holman G D. Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein-kinase dependent reduction in GLUT4 endocytosis. Endocrinology 2006, 147:2728-2736.
48. Karnieli E, Armoni M. Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology. Am J Physiol Endocrinol Metab 2008, 295:E38-E45.
49. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994, 79:872-878.
50. Armoni M, Harel C, Karnieli E. Transcriptional regulation of the GLUT4 gene: from PPAR-γ and FOXO1 to FFA and inflammation. Trends Endocrinol Metabol 2007, 18:100-107.
51. Melnik B, Schmitz G, Zouboulis C C. Anti-acne agents attenuate FGFR2 signal transduction in acne. J Invest Dermatol 2009, Epub ahead of print] doi
52. Hembree J R, Harmon C S, Nevins T D, Eckert R L. Regulation of human dermal papilla cell production of insulin-like growth factor binding protein-3 by retinoic acid, glucocorticoids, and insulin-like growth factor-1. J Cell Physiol 1996, 167:556-561.
53. Boudou P, Chivot M, Vexiau P. Evidence for decreased androgen 5α reduction in skin and liver of men with severe acne after 13-cis retinoic acid treatment. J Clin Endocrinol Metab 1994, 78:1064-1069.
54. Nelson A M, Gilliland K L, Cong Z, Thiboutot D M. 13-cis retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol 2006, 126:2178-2189.
55. Boudou P, Soliman H, Chivot M. Effect of oral isotretinoin treatment on skin androgen receptor levels in male acneic patients. J Clin Endocinol Metab 1995, 80:1158-1161.
56. Melnik B, Vakilzadeh F, Aslanidis C, Schmitz G. Unilateral segmental acneiform nevus - a model disorder towards understanding FGFR2 function in acne?. Br J Dermatol 2008, 158:1397-1399.
57. Plewig G, Fulton J E, Kligman A M. Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch 1971, 242:12-29.
58. Schroeder M, Zouboulis C C. All-trans-retinoic acid and 13-cis-retinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes. Horm Metab Res 2007, 39:136-140.
59. Ibáñez L, Valls C, Marcos M V, Ong K, Dunger D B, De Zegher F. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 2004, 89:4331-4337.
60. Larnkjaer A, Ingstrup H K, Schack-Nielsen L. Early programming of the IGF-I axis: negative association between IGF-I in infancy and late adolescence in a 17-year longitudinal follow-up study of healthy subjects. Growth Hormone IGF Research 2009, 19:82-86.
61. Akcakus M, Koklu E, Kurtoglu S, Kula M, Koklu S S. The relationship among intrauterine growth, insulin-like growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants. Am J Perinatol 2006, 23:473-480.
62. Ibánez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998, 83:3558-3662.
63. Norman R, Dewailly D, Legro R S, Hickey T E. Polycystic ovary syndrome. Lancet 2007, 370:685-697.
64. Thierry van Dessel H J, Lee P D, Faessen G, Fauser B C, Giudice L C. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. J Clin Endocrinol Metabol 1999, 84:3030-3035.
65. Tan S, Hahn S, Benson S. Metformin improves polycystic ovary syndrome symptoms irrespective of pretreatment insulin resistance. Eur J Endocrinol 2007, 157:669-676.
66. De Leo V, Musacchio M C, Morgante G, Piomboni P, Petraglia F. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod 2006, 21:2252-2256.
67. Burton J L, Libman L J, Cunliffe W J, Wilkinson R, Hall R, Shuster S. Sebum excretion in acromegaly. Br Med J 1972, i:406-408.
68. Rosenbloom A L. The role of recombinant insulin-like growth factor I in the treatment of the short child. Curr Opin Pediatr 2007, 19:458-464.
69. Klinger B, Anin S, Silbergeld A, Eshet R, Laron Z. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol 1998, 48:81-87.
70. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton S B, Brand-Miller J. Acne vulgaris. A disease of Western civilization. Arch Dermatol 2002, 138:1584-1590.
71. Smith R, Mann N, Braue A, Mäkeläinen H, Varigos G A. The effect of a high protein, low glycemic load diet versus a conventional, high glycemic load diet on biochemical parameters associated with acne vulgaris. J Am Acad Dermatol 2007, 57:247-256.
72. Smith R, Mann N, Mäkeläinen H, Roper J, Braue A, Varigos G. A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol Nutr Food Res 2008, 52:718-726.
73. Adebamowo C A, Spiegelman D, Berkey C S. Milk consumption and acne in adolescent girls. Dermatol Online J 2006, 12:1-12.
74. Adebamowo C A, Spiegelman D, Berkey C S. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008, 58:787-793.
75. Danby F W. Acne, dairy and cancer. Dermato-Endocrinology 2009, 1:9-13.
76. Blum J W, Baumrucker C R, Bösze Z. Insulin-like growth factors (IGFs), IGF binding proteins, and other endocrine factors in milk: role in the newborn. Bioactive Components of Milk. Advances in Experimental Medicine and Biology 2008, 397-422. In, ed, New York, Springer, vol. 606, pp
77. Hoppe C, Udam T R, Lauritzen L, Mølgaard C, Juul A, Michaelsen K F. Animal protein intake, serum insulin-like growth factor I, and growth in healthy 2.5-y-old Danish children. Am J Clin Nutr 2004, 80:447-452.
78. Hoppe C, Molgaard C, Juul A, Michaelsen K F. High intakes of skimmed milk, but not meat increase serum IGF-I and IGFBP-3 in eight-year-old boys. Eur J Clin Nutr 2004, 58:1211-1216.
79. Hoppe C, Molgaard C, Vaag A, Barkholt V, Michaelsen KF. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr 2005, 59:393-398.
80. Rogers I S, Gunnell D, Emmett P M, Glynn L R, Dunger D B, Holly J M. Cross-sectional associations of diet and insulin-like growth factor levels in 7- to 8-year-old children. Cancer Epidemiol Biomarkers Prev 2005, 14:204-212.
81. Esterle L, Sabatier J P, Guillon-Metz F. Milk, rather than other foods, is associated with vertebral bone mass and circulating IGF-1 in female adolescents. Osteoporos Int 2009, 20:567-575.
82. Norat T, Dossus L, Rinaldi S. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 2007, 61:91-98.
83. Rich-Edwards J W, Ganmaa D, Pollak M N. Milk consumption and the prepubertal somatotropic axis. Nutr J 2007, 6:28. DOI
84. Östman E M, Liljeberg Elmstahl H G M, Björck I M E. Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr 2001, 74:96-100.
85. Hoyt G, Hickey M S, Cordain L. Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk. Br J Nutr 2005, 93:175-177.
86. Gannon M C, Nuttal F Q, Krezowski P A, Billington C J, Parker S. The serum insulin and plasma glucose responses to milk and fruit in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1986, 29:784-791.
87. Holt S, Brand Miller J, Petocz P. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr 1997, 66:1264-1276.
88. Liljeberg E H, Bjorck I. Milk as a supplement to mixed meals may elevate postprandial insulinaemia. Eur J Clin Nutr 2001, 55:994-999.
89. Lucas A, Sarson D L, Blackburn A M, Adrian T E, Aynsley-Green A, Bloom S R. Breast vs bottle: endocrine responses are different with formula feeding. Lancet 1980, 1:1267-1269.
90. Hoppe C, Molgaard C, Michaelsen K F. Cow's milk and linear growth in industrialized and developing countries. Annu Rev Nutr 2006, 26:131-173.
91. Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges 2007, 5:110-117.
92. Melnik B C. Androgen abuse in the community. Curr Opin Endocrinol Diabetes Obes 2009, 16:218-223.
93. Facchini F S, Hollenbeck C B, Jeppesen J. Insulin resistance and cigarette smoking. Lancet 1992, 339:1128-1130.
94. Hautanen A, Adlercreutz H. Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers. Diabetologia 1993, 36:1275-1281.
95. Ghodsi S Z, Orawa H, Zouboulis C C. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 2009, [Epub ahead of print, DOI
96. Capitanio B, Sinagra J L, Ottaviani M. 'Smoker's acne': a new clinical entity?. Br J Dermatol 2007, 157:1070-1071. Epub 2007 Sep 18
97. Revuz J E, Canoui-Poitrine F, Wolkenstein P. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008, 59:596-601.
98. Kurzen H, Kurokawa I, Jemec G B. What causes hidradenitis suppurativa?. Exp Dermatol 2008, 17:455-456.
99. Sutcliffe S, Giovannucci E, Isaacs W B, Willett W C, Platz E A. Acne and risk of prostate cancer. Int J Cancer 2007, 121:2688-2692.
100. Druckmann R, Rohr U D. IGF-1 in gynaecology and obstetrics: update 2002. Maturitas 2002, 41(Suppl. 1):S65-S83.
101. Boyd D B. Insulin and cancer. Integr Cancer Ther 2003, 2:315-329.
102. Pollack M N. Insulin, insulin-like growth factors, insulin resistance, and neoplasia. Am J Clin Nutr 2007, 86:820-822.
103. Clemmons D R. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nature Rev 2007, 6:821-833.
104. Riedemann J, Macauly V M. IGFR1 signalling and its inhibition. Endocr Relat Cancer 2006, 13:S33-S43.